Cocrystal Pharma announces up to $13M registered direct offering at $1.70/share

Cocrystal Pharma, Inc.

$4.7M upfront from sale of 2,764,710 shares at $1.70; closing expected Sep 15, 2025.
Concurrent private placement of warrants to purchase up to 5,529,420 shares at $1.50, exercisable on issuance, 24-month term.
Potential additional gross proceeds of ~$8.3M if warrants fully exercised on cash basis.
H.C. Wainwright & Co. acting as exclusive placement agent.
Net proceeds to be used for working capital and general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.